Direct-to-Consumer (DTC) Advertising
Amgen's mission is to serve patients, and that includes providing them with accurate information about diseases and medicines. Where appropriate and allowed by law, DTC advertising is part of Amgen's patient education efforts.
We follow voluntary industry guidelines governing the responsible use of DTC advertising.
Responsible direct-to-consumer (DTC) advertising can play a role in increasing awareness about diseases, educating patients about treatment options, and fostering dialogue between patients and their healthcare providers. We have a responsibility to consider and evaluate on an ongoing basis the most appropriate settings for where and when we employ DTC advertising as an avenue to reach patients.
Amgen also recognizes that patients and consumers can benefit from greater transparency and education about access to medicines, including the potential costs and resources that may help patients with the cost of their medicine. Amgen supports a proactive, consumer-oriented approach focused on providing information about a medicine's price, including potential out-of-pocket costs, and Amgen-sponsored financial assistance that might be available. Effective April 2019, list prices have been added to our DTC product websites to help U.S. patients make more informed decisions about their health care. The example shown below is from our website for Aimovig®.
In addition, Amgen has voluntarily adopted the Pharmaceutical Research and Manufacturers of America (PhRMA) Guiding Principles on Direct-to-Consumer Advertisements about Prescription Medicine. For more information or to read the PhRMA Guiding Principles, please visit the PhRMA website .
For more information about how patients can access their medicines, please visit https://www.amgensupportplus.com/ .
As of August 4, 2023